Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Daily Values

Growth Metrics

Others

GeneDx Holdings (WGS) Preferred Stock Liabilities (2020 - 2021)

GeneDx Holdings has reported Preferred Stock Liabilities over the past 2 years, most recently at $334.4 million for Q2 2021.

Quarterly Preferred Stock Liabilities rose 54.04% to $334.4 million in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $334.4 million through Jun 2021, up 54.04% year-over-year, with the annual reading at $334.4 million for FY2020, 54.04% up from the prior year.
Preferred Stock Liabilities was $334.4 million for Q2 2021 at GeneDx Holdings, roughly flat from $334.4 million in the prior quarter.
Over five years, Preferred Stock Liabilities peaked at $334.4 million in Q3 2020 and troughed at $217.1 million in Q2 2020.